Editas Medicine Announces Third Quarter 2025 Results and Business Updates

In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates ...
The Brighterside of News on MSN

First human trial of a CRISPR-based treatment significantly lowered cholesterol and ...

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...